In Brief Chu et al. show that glutamatergic corticosubthalamic transmission heterosynaptically regulates the strength of GABAergic pallidosubthalamic inhibition. Under normal conditions, this mechanism homeostatically balances synaptic excitation and inhibition. However, in experimental Parkinson's disease, heterosynaptic regulation drives pathological strengthening of pallidosubthalamic inputs.
INTRODUCTION
The basal ganglia are a group of subcortical brain nuclei critical for voluntary movement and the primary site of dysfunction in movement disorders like Parkinson's disease (PD) (Albin et al., 1989; Galvan and Wichmann, 2008; Hammond et al., 2007; Kravitz et al., 2010) . Cortical excitation of the basal ganglia is processed via the direct, hyperdirect, and indirect pathways (Nambu et al., 2002; Smith et al., 1998) , the relative activities of which are dynamically regulated by dopaminergic transmission (Albin et al., 1989; Gerfen and Surmeier, 2011) . Direct pathway activity promotes movement through inhibition of GABAergic basal ganglia output (Chevalier and Deniau, 1990; Hikosaka et al., 2000; Kravitz et al., 2010) , whereas the hyperdirect and indirect pathways suppress movement through elevation of basal ganglia output (Baunez et al., 1995; Kravitz et al., 2010; Maurice et al., 1999; Tachibana et al., 2008) . The hyperdirect pathway conveys cortical excitation to basal ganglia output nuclei via the glutamatergic subthalamic nucleus (STN) (Maurice et al., 1999; Tachibana et al., 2008) and, therefore, mediates a rapid stop/pause signal prior to direct pathway inhibition (Baunez et al., 1995; Nambu et al., 2002; Mink and Thach, 1993) . The indirect pathway, which traverses the striatum, GABAergic external globus pallidus (GPe), and STN, elevates basal ganglia output more slowly and, therefore, terminates movements selected by the direct pathway (Albin et al., 1989; Kravitz et al., 2010; Maurice et al., 1999; Mink and Thach, 1993; Tachibana et al., 2008) . In idiopathic and experimental PD, an increase in hyperdirect/indirect pathway activity and abnormally correlated hyperdirect/indirect pathway activity contribute to motor dysfunction (Albin et al., 1989; Galvan and Wichmann, 2008; Hammond et al., 2007; Jenkinson and Brown, 2011; Kravitz et al., 2010) .
The intersection of the hyperdirect and indirect pathways argues that the STN is a key locus of interaction. Indeed, GPe inhibition acting at GABA A receptors (GABA A Rs) potently shunts/ limits coincident cortical excitation of the STN (Atherton et al., 2010; Fujimoto and Kita, 1993; Maurice et al., 1998) but promotes cortical patterning if it is offset in phase to cortical excitation (Baufreton et al., 2005; Mallet et al., 2008a Mallet et al., , 2012 Paz et al., 2005) . This promotion of cortical patterning is due to both disinhibition and increased availability of postsynaptic Na v and Ca v channels postinhibition (Baufreton et al., 2005; Hallworth and Bevan, 2005; Hallworth et al., 2003; Otsuka et al., 2001) . Interestingly, GPe-STN inhibition is phase-offset to motor cortical excitation in idiopathic and experimental PD, most likely because of abnormal hyperactivity of GABAergic striatopallidal neurons, and may, therefore, promote excessive cortical patterning of the STN (Baufreton et al., 2005; Galvan and Wichmann, 2008; Hammond et al., 2007; Jenkinson and Brown, 2011; Mallet et al., 2006; 2008a Shimamoto et al., 2013; Tachibana et al., 2011) . In addition, the strength of GPe-STN inputs increases profoundly following loss of dopamine, which may further intensify abnormal, correlated activity (Fan et al., 2012) .
The balance of synaptic excitation and inhibition is critical to the operation of brain microcircuits and is often perturbed in disease (Turrigiano, 2011) . In complex microcircuits, the relative strengths of glutamatergic and GABAergic synaptic transmission rise and fall in unison or shift in opposite directions, depending on the prevailing pattern and level of cellular and network activity (Turrigiano, 2011) . We therefore hypothesized that (1) the STN likely possesses an intrinsic homeostatic mechanism that regulates the balance of incoming hyperdirect cortical excitation and indirect pathway GPe inhibition and (2) excessive engagement of this regulatory mechanism by parkinsonian hyperdirect and indirect pathway activity triggers abnormal strengthening of GPe-STN transmission. Because plasticity at GABAergic synapses is typically heterosynaptic and driven by glutamatergic transmission (Castillo et al., 2011) , we first tested whether motor cortical inputs heterosynaptically regulate GPe-STN transmission and then whether motor cortical inputs drive the pathological strengthening of GPe-STN transmission that follows the loss of dopamine.
RESULTS

Optogenetic Stimulation of Motor Cortical Inputs and Electrical Stimulation of GPe-STN Inputs Ex Vivo
To determine how motor cortical inputs regulate the strength of GPe-STN transmission, a combined optogenetic and electrical stimulation approach was employed in adult mice to selectively stimulate motor cortex-STN and GPe-STN transmission, respectively, ex vivo. Stereotaxic injection of an adeno-associated viral (AAV) vector was used to express ChR2(H134R)-eYFP in motor cortical neurons and their axon terminals in the STN (Afsharpour, 1985; Kita and Kita, 2012; Monakow et al., 1978) (Figure 1 ). Injections were centered on the forelimb representation, as defined by a recent microstimulation study (Tennant et al., 2011) . Robust optogenetic excitation of motor cortical projections to the STN (Figure 1 ) was subsequently confirmed with patch-clamp recording. Optogenetic stimulation of motor cortex-STN axon terminals generated glutamatergic excitatory postsynaptic currents (EPSCs) in STN neurons (Figure 1 ). These EPSCs were sensitive to the AMPA receptor (AMPAR) antagonist GYKI53665 (50 mM) and the NMDA receptor (NMDAR) antagonist D(À)-2-Amino-5-phosphonopentanoic acid (D-APV) (50 mM) ( Figure 1D , n = 7). Pharmacologically isolated AMPAR-and NMDAR-mediated components of motor cortex-STN EPSCs exhibited typical, distinct voltage dependencies and kinetics ( Figure 1E ; Figure S1 available online; n = 6; Jonas, 1993) . Focused bipolar electrical stimulation of the internal capsule rostral to the STN (in the presence of 1 mM CGP55845, a GABA B receptor (GABA B R) antagonist) was used to evoke GABA A R-mediated transmission (Bevan et al., 2002) . Given that the GPe provides by far the major GABAergic input to the STN (Baufreton et al., 2009; Bevan and Bolam, 1995; Smith et al., 1990) , GABA A R-mediated inhibitory postsynaptic currents (IPSCs) were assumed to arise from GPe-STN transmission. Through this approach, IPSCs were typically evoked in isolation. However, smaller, glutamatergic EPSCs were also generated occasionally and, therefore, routinely eliminated by application of the AMPAR antagonist 6,7-dinitroquinoxaline-2,3(1H,4H)-dione (DNQX) (20 mM).
Optogenetic Stimulation of Motor Cortex-STN Inputs
Leads to Heterosynaptic Long-Term Potentiation (hLTP) of GPe-STN Transmission Ex Vivo Baseline GPe-STN transmission was first monitored under voltage clamp at -60 mV for 5-10 min. Motor cortex-STN inputs were then stimulated optogenetically in a pattern (1 ms light pulses delivered at 50 Hz for 300 ms, with stimulus trains repeated 30 times at 0.2 Hz) that mimicked bursts of activity in motor cortical projection neurons in vivo during voluntary movement (Isomura et al., 2009) . During optogenetic stimulation, STN neurons were recorded in current clamp mode and were strongly driven by cortical excitation acting at STN NMDARs (as stated above, AMPARs were blocked with DNQX) (Figure 2A ). The subsequent impact of cortical excitation on GPe-STN transmission was then monitored under voltage clamp at -60 mV for $40 min longer. Data are reported as median and interquartile range. Within 5 min of optogenetic stimulation, GPe-STN IPSCs started to increase in amplitude, and, after $40 min, GPe-STN IPSC amplitudes had increased by 44, 30 to 53% (n = 9, p < 0.05) versus baseline transmission prior to stimulation (Figures 2A-2C ). To determine whether an increase in postsynaptic activity alone (Kurotani et al., 2008; Peng et al., 2010; Wang et al., 2006) mediated the potentiation of GPe-STN transmission, STN neurons were driven to a similar degree and in a similar pattern through somatic current injection (20-40 pA for 300 ms, repeated 30 times at 0.2 Hz) in place of synaptic excitation ( Figure 2D ). However, in contrast to synaptic excitation, current injection did not lead to an increase in the strength of GPe-STN transmission (0, -7 to 7% (n = 6, p > 0.05) (Figures 2D-2F ). Together, these data demonstrate that motor cortex-STN transmission can generate hLTP of GPe-STN transmission ex vivo.
To determine whether hLTP can balance the LTP of motor cortex-STN transmission, the impact of the same optogenetic induction protocol on motor cortex-STN inputs was first tested. The motor cortex-STN EPSC was recorded at À80 mV, and AMPARs were not blocked in these experiments. Optogenetic induction led to LTP of motor cortex-STN transmission in the majority of STN neurons tested (10 of 14 exhibited LTP, 3 of 14 exhibited no plasticity, and 1 of 14 exhibited long-term depression (LTD) (Figures S2A-S2C) . Overall, the induction protocol increased the amplitude of motor cortex-STN transmission by 42, -1.6 to 61% (n = 14, p < 0.05). In neurons that exhibited LTP, the amplitude of motor cortex-STN transmission increased by 49, 41 to 99% (n = 10, p < 0.05). Next, optogenetically evoked motor cortex-STN EPSCs and electrically evoked GPe-STN IPSCs were monitored at -80 mV and -60 mV, respectively, in the same neuron before and after optogenetic induction ( Figures  2G-2J ). In five neurons tested, both the EPSC and IPSC potentiated to a similar extent, confirming that LTP of motor cortex-STN transmission is balanced by hLTP of GPe-STN transmission ( Figures 2G-2J) . As a result, the ratio of excitation to inhibition pre-and postinduction was similar (preinduction = 0.45, 0.45 to 0.62; postinduction = 0.46, 0.45 to 0.59; n = 5; p > 0.05). We next sought to dissect the mechanisms underlying hLTP.
Activation of Postsynaptic NMDARs Is Required for hLTP
Because AMPARs were usually antagonized with DNQX when studying hLTP, activation of these receptors was not required for hLTP of GPe-STN transmission. Although activation of group 1 metabotropic glutamate receptors (mGluRs) triggers hLTP of GABA A R-mediated transmission in hippocampal pyramidal neurons (Patenaude et al., 2003) , additional antagonism of group 1 mGluRs with 50 mM 7-hydroxyiminocyclopropanbchromen1a-carboxylate ethyl ester (CPCCOEt) and 10 mM 6-methyl-2-(phenylethynyl)pyridine hydrochloride (MPEP) also did not prevent hLTP (32, 18 to 36%; n = 6; p < 0.05) ( Figure 3A ). In contrast, blockade of NMDARs, a more common trigger of GABAergic transmission plasticity (Marsden et al., 2007; Nugent et al., 2007; Ouardouz and Sastry, 2000) , with D-APV (50 mM) completely eliminated hLTP (2, -2 to 6%; n = 7; p > 0.05) (Figure 3A) . Furthermore, application of 50 mM NMDA for 5 min induced robust LTP of GPe-STN transmission (48, 35 to 53%; n = 6; p < 0.05) ( Figure 3B ). Given that brain slices were prepared from mice that had been anesthetized with ketamine, an NMDAR antagonist, a subset of mice (n = 3) was anesthetized with isoflurane to determine whether hLTP was influenced by the anesthetic. hLTP was also reliably generated in these mice (51, 30 to 85%; n = 4) suggesting that the observations reported here were not greatly affected by the choice of anesthetic.
Because NMDARs are permeable to Ca 2+ , they typically contribute to synaptic plasticity through an elevation of intracellular Ca 2+ and activation of Ca
2+
-dependent signaling pathways (Castillo et al., 2011; Marsden et al., 2007; Nugent et al., 2007; Ouardouz and Sastry, 2000) . To determine the location of the NMDAR-Ca 2+ signaling cascade necessary for hLTP, the Ca 2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N 0 ,N'-tetraacetic acid (BAPTA) (20 mM) or the specific Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) inhibitor autocamtide-2-related inhibitory peptide (AIP, 50 mM) were infused via a patch pipette into the recorded postsynaptic neuron. Chelation of postsynaptic Ca 2+ with BAPTA completely prevented hLTP (0, -6 to 7%; n = 6; p > 0.05) ( Figure 3C ). Inhibition of postsynaptic CaMKII also eliminated hLTP and replaced it with LTD of GPe-STN transmission (-44, -52 to -30%; n = 7; p < 0.05) ( Figure 3D) . Together, these data demonstrate that activation of postsynaptic NMDARs, Ca 2+ entry, and protein kinase activation are required for hLTP. Interestingly, blockade of NMDARs also prevented LTP of motor cortex-STN synapses (-5, -7 to 0%; n = 6; p > 0.05), demonstrating that both hLTP and LTP are dependent on NMDAR activation ( Figures S2D-S2F ).
hLTP Involves Insertion of GABA A Rs into the Postsynaptic Membrane hLTP in other brain circuits is mediated by pre-and/or postsynaptic alterations (Castillo et al., 2011) . To isolate the contribution of postsynaptic alterations, STN neurons (n = 7) were imaged using two-photon laser scanning microscopy (2PLSM) (Atherton et al., 2010) , and (bis(2,2'-bipyridine-N,N')triphenylphosphine)-4-aminobutyric acid ruthenium hexafluorophosphate complex (RuBi-GABA) (10-20 mM) was spot-uncaged at soma or dendrites 33, 30 to 57 mm from the soma (Figure 4 ; Figure S3 ). The distance from the somatic (and dendritic) membrane at which negligible GABA A R current was evoked was $20 mm ( Figure S3 ), implying that uncaging at STN somata, which are approximately 10-15 mm in diameter, largely activated somatic and proximal dendritic GABA A Rs, whereas uncaging at dendrites >20 mm from the soma largely activated dendritic GABA A Rs. Bath application of NMDA (50 mM for 5 min) enhanced the amplitude of the current evoked by 1 ms uncaging of RuBi-GABA at both somatic (45, 14 to 61%; n = 6; p < 0.05) and dendritic locations (16, 11 to 23%; n = 7; p < 0.05) ( Figures 4A and 4B ). These observations suggest that NMDAR activation leads to an increase in the expression of GABA A Rs in the somatodendritic membrane of STN neurons (Marsden et al., 2007) . Rapid soluble NSF attachment protein receptor (SNARE)-dependent insertion of synaptic receptors into the plasma membrane may contribute to LTP at both glutamatergic and GABAergic synapses (Lu et al., 2001; Ouardouz and Sastry, 2000) . To test the contribution of receptor insertion to hLTP, the vesicle-associated membrane protein (VAMP) inhibitor tetanus toxin (20 nM) or its heat-inactivated form were infused into the postsynaptic neuron via the recording pipette prior to optogenetic stimulation of motor cortex-STN inputs. Optogenetic induction of hLTP was prevented by intracellular infusion of tetanus toxin (2, -3 to 12%; n = 7; p > 0.05) (Figures 4C and 4D) , whereas infusion of heat-inactivated tetanus toxin (20 nM) had no effect (52, 34 to 64%; n = 5; p < 0.05) (Figures 4C and 4D) . Together, these data demonstrate that hLTP is mediated, at least in part, by insertion of GABA A Rs into the somatodendritic membrane of STN neurons.
hLTP Is Associated with an Increase in the Probability of GPe-STN Transmission To determine how the probability of GPe-STN transmission was altered by hLTP, the ratio of two GPe-STN IPSCs stimulated with a 50 ms interval was measured before and after optogenetic stimulation of motor cortical inputs. hLTP was associated with a small but significant decrease in the ratio of IPSC2:IPSC1 amplitude (preinduction = 0.86, 0.84 to 0.88; postinduction = 0.79, 0.77 to 0.80; n = 9; p < 0.05) ( Figures 5A and 5B). hLTP was also associated with a reduction in the coefficient of variation (CV) of IPSC1 amplitude so that there was a profound increase in 1/CV 2 of IPSC1 (preinduction = 96, 56 to 143; postinduction = 252, 90 to 435; n = 9; p < 0.05) ( Figure 5C ). Together, these data suggest that hLTP is associated with an increase in the probability of GPe-STN transmission. An analogous approach was applied to determine how the probability of motor cortex-STN transmission was altered following induction of LTP. In contrast to hLTP, the ratio of EPSC2:EPSC1 was unaltered following LTP, suggesting that LTP was largely postsynaptic in nature (preinduction = 1.02, 1.00 to 1.11; postinduction = 1.00, 0.95 to 1.06; n = 10; p > 0.05) (data not shown). Given that the motor cortex-STN EPSC evoked at À80 mV is mediated largely by AMPARs, LTP is therefore likely due to an increase in postsynaptic AMPAR current. The amplitude and frequency of spontaneous GABA A R-mediated IPSCs (sIPSCs) were also compared in STN neurons that received optogenetic stimulation and, as a control, in neurons that did not. Recordings commenced at least 40 min after the induction protocol was initiated or, for control slices, at an analogous time point. The frequency of GPe-STN sIPSCs was greater in neurons from stimulated slices (nonstimulated = 23, 21 to 34 Hz, n = 11; stimulated = 36, 30 to 48 Hz, n = 13; p < 0.05) ( Figures  5D-5F ). However, the amplitude of sIPSCs was not altered by optogenetic stimulation (non-stimulated = 28, 21 to 30 pA, n = 11; stimulated = 27, 24 to 29 pA, n = 13; p > 0.05) (Figures 5D-5F ). STN neurons from each group received a similar level of motor cortical innervation, as evidenced by the amplitude of optogenetically stimulated EPSCs (non-stimulated = 220, 158 to 349 pA, n = 11; stimulated = 303, 152 to 490 pA, n = 13; p > 0.05) ( Figure 5G ).
Together, these data demonstrate that the overall level of GPe-STN transmission increases following hLTP but that the amplitude of individual sIPSCs is unaltered. Given the postsynaptic component of hLTP, described above, one possibility is that an increase in the number of functional synapses underlies hLTP (Clements and Silver 2000; Malenka and Nicoll, 1999) .
Involvement of NO Signaling in hLTP NMDAR-dependent activation of postsynaptic nitric oxide (NO) synthase (NOS), release of NO and activation of presynaptic guanylate cyclase (GC) -protein kinase G (PKG) signaling has been shown to mediate an increase in GABAergic transmission probability in several brain circuits (e.g., Nugent et al., 2007; Lange et al., 2012) . Because STN neurons express NOS (Nisbet et al., 1994) and GPe neurons express soluble GC (Pifarré et al., 2007) , the involvement of NO signaling in hLTP of GPe-STN transmission was tested. Incubation of brain slices with the membrane-permeable NOS inhibitor Nu-nitro-L-arginine methyl ester hydrochloride (L-NAME) (100 mM) for 30 min prevented the optogenetic induction of hLTP (5, 0 to 11%; n = 8; p > 0.05) ( Figure 6A ). hLTP was also blocked by bath application of the NO scavenger carboxy-PTIO (c-PTIO) (30 mM) (3, 1 to 7%; n = 6; p > 0.05) (Figure 6B) , the membrane-permeable GC inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 mM) (-3, -7 to 5%; n = 6; p > 0.05) ( Figure 6C ), and the membrane-permeable PKG inhibitor KT5823 (1 mM) (-2, -7 to 1%; n = 5; p > 0.05) ( Figure 6D ). However, inhibition of postsynaptic PKG activity alone by inclusion of a membrane-impermeable PKG inhibitory peptide (100 mM) in the recording pipette did not prevent hLTP (54, 42 to 59%; n = 6; p < 0.05) ( Figure 6E ). Together with the above data, these results are consistent with the conclusion that NMDAR-dependent activation of postsynaptic NOS leads to the liberation of NO from STN neurons and activation of GC and PKG in GPe-STN axon terminals. Indeed, continuous application of the NOS inhibitor L-NAME (100 mM) did not prevent the potentiation of GABA A R current evoked by somatic uncaging of RuBi-GABA following 5 min of NMDA (50 mM) administration (46, 23 to 51%; n = 6; p < 0.05) ( Figure 6F ). Therefore, NO signaling is not required for the insertion of GABA A Rs into the postsynaptic membrane. Finally, application of the NO donor S-nitroso-N-acetyl-DL-penicillamine (100-200 mM) did not lead to potentiation of GPe-STN inputs (-1, -10 to 6%; n = 9; p > 0.05) (data not shown), demonstrating that, although NO signaling is necessary, it is not sufficient for hLTP in the absence of NMDAR activation.
hLTP Is Associated with Alterations in GABAergic Synaptic Markers To test whether structural changes are associated with hLTP, brain slices were subjected to optogenetic or chemical (50 mM NMDA for 5 min) induction protocols or left untreated. 40 min later, brain slices were briefly immersion-fixed with paraformaldehyde (PFA). The densities of structures expressing GABAergic postsynaptic and presynaptic markers were then assessed by immunohistochemistry. The scaffolding protein gephyrin and the GABA A R subunit g2 were used as postsynaptic markers, and the vesicular GABA transporter and the active zone protein bassoon were used as presynaptic markers. In slices that contained high densities of ChR2(H134R)-eYFP-expressing motor cortex-STN axon terminals, there was a significantly higher density of gephyrin-immunoreactive structures in optogenetically stimulated slices (nonstimulated = 12, 9 to 21 million/mm 3 , n = 17; stimulated = 20, 13 to 34 million/mm 3 , n = 17; p < 0.05) ( Figures S4A, S4B , and S4E). In contrast, optogenetic stimulation did not alter the density of gephyrin-immunoreactive structures in slices that contained few ChR2(H134R)-eYFP-expressing motor cortex-STN axon terminals (nonstimulated = 15, 11 to 16 million/mm 3 , n = 13; stimulated = 15, 11 to 18 million/mm 3 , n = 13; p > 0.05) ( Figures S4C-S4E ).
Although optogenetic stimulation produced a clear increase in the density of gephyrin-immunoreactive structures, the resolution of this and other synaptic markers was further optimized for subsequent experiments by increasing the magnification of the objective from 403 to 1003 and the digital zoom from 2.53 to 53. As a result, the apparent density of detectable gephyrinimmunoreactive structures increased. Administration of NMDA to slices increased the density of gephyrin-immunoreactive structures 40 min after treatment compared with untreated slices (Figures 7C, 7D , and 7F). The density of bassoon-immunoreactive structures in vGATimmunoreactive GABAergic axon terminals was also studied to estimate the number of active zones pre-and postinduction. NMDA treatment moderately but significantly increased the number of active zones in vGAT-immunoreactive GABAergic axon terminals (control = 74, 69 to 92 million/mm 3 , n = 14; NMDA = 94, 78 to 103 million/mm 3 , n = 14; p < 0.05) ( Figures 7C, 7D , and 7F). The mean absolute fluorescence intensity and size of individual, stereologically selected, immunoreactive, pre-and postsynaptic structures were not significantly different in tissue sections that were or were not subjected to optogenetic or chemical induction (data not shown). Taken together, these data demonstrate that hLTP is associated with an increase in the density of postsynaptic and (to a lesser extent) presynaptic markers, whereas the density of GABAergic axon terminals remains constant.
Knockdown of STN NMDARs Reduces GABAergic GPe-STN Transmission in Control and Dopamine-Depleted Mice
Following chronic depletion of dopamine in the 6-hydroxydopamine (6-OHDA) lesion model of PD, GPe-STN transmission is profoundly augmented ($40%-100%) through an increase in the number of functional synapses, with no alteration in the number of GPe-STN axon terminals (Fan et al., 2012) . The nature of this augmentation and the increased patterning of the disinhibited STN by cortical inputs in idiopathic and experimental PD, in light of this study, imply that cortical-driven hLTP of GPe-STN transmission in vivo is responsible (Hammond et al., 2007; Jenkinson and Brown, 2011; Mallet et al., 2008a Mallet et al., , 2012 Shimamoto et al., 2013) . If this hypothesis is correct, then knockdown of STN NMDARs should prevent strengthening of GPe-STN transmission in experimental PD. To determine how NMDAR activation in vivo regulates GPe-STN transmission, AAV vectors expressing cre recombinase (cre)-eGFP or eGFP were injected into the STN of Grin1 lox/lox transgenic mice (Tsien et al., 1996) to knock down STN NMDARs and to control for AAV infection, respectively. During the same surgery, the neurotoxin 6-OHDA or vehicle was injected into the medial forebrain bundle to lesion midbrain dopamine neurons and to control for injection surgery, respectively. Two to three weeks later, excitatory and miniature (m) GPe-STN transmission were measured in infected neurons under 2PLSM or epifluorescent microscopic guidance ex vivo (Figure 8) . Knockdown of the obligatory NMDAR subunit GluN1 was first confirmed by analyzing the NMDA:AMPA ratio of electrically evoked and pharmacologically isolated glutamatergic EPSCs. The NMDA:AMPA ratio was reduced in cre-eGFP-expressing STN neurons compared with eGFP-expressing STN neurons in dopamine-intact mice (eGFP = 0.22, 0.21 to 0.30, n = 7; cre- Figures 8D and 8E ). In 6-OHDA-injected mice, chronic dopamine depletion was verified using immunohistochemistry for striatal tyrosine hydroxylase (TH) (vehicle, ipsilateral:contralateral striatal TH immunoreactivity = 100, 95 to 105%, n = 6; 6-OHDA, ipsilateral:contralateral striatal TH immunoreactivity = 2, 0 to 6%, n = 7; p < 0.05). Consistent with earlier findings (Fan et al., 2012) , chronic dopamine depletion led to an increase in the frequency (vehicle eGFP = 13.5, 7.7 to 22.1 Hz, n = 45; 6-OHDA eGFP = 19.8, 12.6 to 31.5 Hz, n = 45; p < 0.05) but not the amplitude (vehicle eGFP = 31, 28 to 37 pA, n = 45; 6-OHDA eGFP = 30, 26 to 34 pA,; n = 45; p > 0.05) of mIPSCs in eGFP-expressing STN neurons ( Figures 8F and 8G) . Furthermore, knockdown of STN NMDARs in cre-eGFP-expressing STN neurons reduced both the frequency and the amplitude of miniature GPe-STN transmission in both vehicle-injected (vehicle cre-eGFP = 7.4, 4.4 to 10.7 Hz, n = 33, p < 0.05; vehicle cre-eGFP = 23, 21 to 25 pA, n = 33, p < 0.05) and dopaminedepleted mice (6-OHDA cre-eGFP = 5.0, 3.3 to 9.5 Hz, n = 23, p < 0.05; 6-OHDA cre-eGFP = 22, 20 to 26 pA, n = 23, p < 0.05) relative to their eGFP-expressing counterparts from vehicleand dopamine-depleted mice, respectively ( Figures 8F and 8G) . The frequency and amplitude of miniature GPe-STN transmission in cre-eGFP expressing neurons from vehicle-and 6-OHDAtreated mice were reduced to a similar level by NMDAR knockdown (p > 0.05). Together, these data demonstrate that NMDAR activation not only triggers the increase in GPe-STN transmission that follows the loss of dopamine but also positively regulates GPe-STN transmission in control mice.
A corollary prediction is that, following dopamine depletion, motor cortex-STN-driven hLTP reaches a ceiling in vivo that then occludes subsequent induction of hLTP ex vivo. To test this hypothesis, hLTP in slices taken from mice that had received injections of 6-OHDA (n = 6) or vehicle (n = 6) in the medial forebrain bundle 2-3 weeks earlier were compared. Profound dopamine depletion in 6-OHDA-treated mice was confirmed, as described above (ipsilateral:contralateral striatal TH immunoreactivity = 3, 0 to 13%, n = 6). Motor cortical inputs to STN neurons were then stimulated optogenetically to induce hLTP of GPe-STN inputs ex vivo, as described above. As predicted, hLTP ex vivo was significantly reduced in neurons from dopamine-depleted mice compared with those from vehicle-injected mice (vehicle = 38, 26 to 65%, n = 6; 6-OHDA = -1, -8 to 9%, n = 8; p < 0.05) (Figures 8H and 8I) . Together with previous studies, the data suggest that, following dopamine depletion, increased motor cortical patterning of STN neurons drives hLTP of GPe-STN transmission in vivo through increased activation of STN NMDARs.
DISCUSSION
The data presented here demonstrate that motor cortical inputs to the STN drive hLTP of GPe-STN transmission. hLTP was (A, B, and E) Bath application of NMDA (50 mM for 5 min) increased the density of gephyrin-immunoreactive structures and the density of gephyrin-immunoreactive structures that were coimmunoreactive for the GABA A R subunit g2 (white arrows).
(C, D, and F) NMDA treatment had no effect on the density of vGAT-immunoreactive structures that were coimmunoreactive for bassoon (BA). However, NMDA treatment did lead to a small but significant increase in the density of bassoon-immunoreactive structures that were coimmunoreactive for vGAT (white arrows). *p < 0.05. See also Figure S4 .
dependent on activation of postsynaptic NMDARs, CaMKII, and NOS. NO acted presynaptically via a GC-cGMP-PKG signaling cascade. hLTP involved rapid SNARE-dependent insertion of GABA A R subunits into the postsynaptic membrane and an increase in the density of synaptic markers with no alteration in the number of GPe-STN axon terminals. Therefore, hLTP was mediated by an increase in functional synapses, consistent with an increase in the frequency but not amplitude of sIPSCs. Motor cortical inputs also exhibited NMDAR-dependent LTP.
In individual neurons, optogenetically induced LTP and hLTP were similar in magnitude, arguing that hLTP helps to balance motor cortical excitation and GPe-STN inhibition. Knockdown of STN NMDARs in vivo reduced the frequency and amplitude of mIPSCs in control mice and prevented the abnormal strengthening of GPe-STN transmission that follows loss of dopamine (Fan et al., 2012) . Following dopamine depletion, hLTP was occluded ex vivo, implying that excessive motor cortical patterning of the STN had maximally augmented GPe-STN transmission in vivo (Jenkinson and Brown, 2011; Hammond et al., 2007; Mallet et al., 2008a Mallet et al., , 2012 Shimamoto et al., 2013) . Although the signaling cascades described here have been shown previously to be involved in hLTP of GABAergic transmission in other brain nuclei, the locus of hLTP in those studies was either postsynaptic or presynaptic (Castillo et al., 2011; Lange et al., 2012; Marsden et al., 2007; Nugent et al., 2007; Ouardouz and Sastry, 2000) . In contrast, hLTP has both pre-and postsynaptic components in the STN. Therefore, activation of postsynaptic NMDARs, Ca 2+ entry, and activation of CaMKII led to SNARE-dependent insertion of GABA A R subunits into the postsynaptic membrane. Furthermore, immunohistochemistry revealed an associated increase in the density of postsynaptic GABA A R g2 subunit-and gephyrin-immunoreactive structures. The relatively high density of structures immunoreactive for the active zone protein bassoon in GABAergic axon terminals compared with the density of postsynaptic markers prior to hLTP suggests that hLTP is mediated in part by insertion of GABA A receptors and scaffolding proteins like gephyrin into receptor-deficient or silent synapses, analogous to the mechanism first described at glutamatergic synapses (Malenka and Nicoll, 1999) . Certainly, g2 GABA A R subunits and gephyrin are key substrates for the assembly of synaptic GABA A R complexes (Luscher et al., 2011; Smith and Kittler, 2010; Tyagarajan and Fritschy, 2010; Vithlani et al., 2011) . Additional molecular partners such as GABAR accessory protein, which is phosphorylated by CaMKII following NMDAR activation, may also be important for trafficking GABA A R subunits and associated molecules to the postsynaptic membrane prior to insertion (Marsden et al., 2007) .
On the presynaptic side, we infer that NO is generated postsynaptically but acts retrogradely on GPe-STN axon terminals because postsynaptic Ca 2+ chelation prevented hLTP, in contrast to postsynaptic PKG inhibition, which had no effect. Furthermore, insertion of GABA A Rs into the postsynaptic membrane, as assessed by RuBi-GABA uncaging, was not altered by inhibition of NOS. The expression of NOS in STN neurons (Nisbet et al., 1994) and sGC in GPe neurons (Pifarré et al., 2007) is consistent with this thesis. The precise action of presynaptic GC-cGMP-PKG signaling in hLTP is unclear. One possibility is that this cascade mobilizes vesicles at synapses that, prior to induction, were deficient in postsynaptic receptors. Indeed, in structures where hLTP is presynaptic, NO-GC-cGMP-PKG signaling mediates an increase in transmission probability (Lange et al., 2012; Nugent et al., 2007) . Interestingly, the predicted but subtle increase in transmission probability due to hLTP in vivo was not detected following chronic dopamine depletion (Fan et al., 2012) . The wide variability in transmission probability is the likely cause for this detection failure. Here the influence of this variability was reduced because transmission probabilities of the same connections were compared before and following optogenetic induction ex vivo. A small but significant increase in the density of bassoon-immunoreactive active zones in GPe-STN axon terminals was also noted 40 min after induction, implying that synaptic proliferation, perhaps on a longer timescale than initial events, also contributes to hLTP. LTP of motor cortex-STN synapses was also NMDAR-dependent and associated with an increase in AMPAR EPSC amplitude with no alteration in paired pulse ratio, implying that it is similar in form to classical LTP (Malenka and Nicoll, 1999) . It has been assumed that the balance of movement suppressing and promoting pathway activity in the basal ganglia is under the control of dopamine and determined within the striatum (Albin et al., 1989; Gerfen and Surmeier, 2011 ). Here we reveal that hyperdirect and indirect pathway interactions are additionally subject to NMDAR-dependent regulation within the STN. Activation of STN NMDARs at motor cortex-STN synapses in vivo is presumably a function of the frequency and pattern of presynaptic activity, synaptic strength, and the integrative state of the postsynaptic neuron. Under normal conditions, GPe-STN inhibition and cortical excitation are poorly correlated and often coincident (Galvan and Wichmann, 2008; Hammond et al., 2007; Jenkinson and Brown, 2011; Magill et al., 2001; Mallet et al., 2008a Mallet et al., , 2012 Tachibana et al., 2011) . Therefore, GPe-STN inhibition is likely to limit, through hyperpolarization and shunting of synaptic excitation, cortical activation of STN NMDARs and the extent of hLTP (and LTP) (Atherton et al., 2010; Fujimoto and Kita, 1993; Maurice et al., 1998) .
Following dopamine depletion, GPe-STN transmission strength increases profoundly (Fan et al., 2012) , and hLTP ex vivo is occluded, implying that strengthening resulted from motor cortical-driven hLTP in vivo. Furthermore, knockdown of STN NMDARs prevented strengthening. But how does loss of dopamine trigger strengthening of GPe-STN inputs? The most likely explanation is that the frequency and pattern of GPe-STN transmission are altered by hyperactive striatopallidal neurons (Albin et al., 1989; Gerfen and Surmeier, 2011; Mallet et al., 2006) and downregulation of GPe hyperpolarization-activated cyclic nucleotide-gated channels (Chan et al., 2011) . As a result, GPe-STN activity is reduced in frequency and offset in phase to motor cortex-STN excitation (Magill et al., 2001; Mallet et al., 2008a Mallet et al., , 2012 , leading to increased activation of STN NMDARs, which, in turn, triggers excessive strengthening of GPe-STN inputs. Although the frequency of motor cortical neuron activity is not altered by loss of dopamine, their firing becomes more synchronous (Goldberg et al., 2002) , which may further promote activation of STN NMDARs. Another, still untested possibility suggested by this study is that motor cortical synapses strengthen through NMDAR-dependent LTP. Indeed, the ratio of whole-cell AMPAR to NMDAR current increases following dopamine depletion (Shen and Johnson, 2005) . However, the STN also receives glutamatergic inputs from the thalamus, pedunculopontine nucleus, and superior colliculus (Bevan and Bolam, 1995; Coizet et al., 2009; Smith et al., 1998) , and the plasticity processes these inputs engage under normal conditions and following loss of dopamine remain to be determined.
Because GPe-STN inhibition is offset in phase relative to cortical excitation in experimental PD, strengthening of GPe-STN synapses may promote pathological activity through deinactivation of postsynaptic Na v and Ca v channels, which underlie rebound burst firing and enhance excitatory synaptic integration at the offset of inhibition (Baufreton et al., 2005; Hallworth et al., 2003; Otsuka et al., 2001) . Indeed, electrophysiological (Baufreton et al., 2005 (Baufreton et al., , 2009 Mallet et al., 2008a Mallet et al., , 2012 Tachibana et al., 2011) and computational (Holgado et al., 2010; Moran et al., 2011; Terman et al., 2002) studies argue that strengthening GPe-STN inputs actually enhances the capability of the GPe (and cortex) to generate abnormal, correlated STN activity. In the 6-OHDA model, it takes days to weeks for the emergence of abnormal activity, implying that circuit plasticity triggered by the loss of dopamine is a key contributor (Mallet et al., 2008b) . Furthermore, in experimental PD, silencing GPe activity abolishes abnormal activity in the STN, suggesting a causative role (Tachibana et al., 2011) . Therefore, together with striatopallidal neurons (Day et al., 2006; Gittis et al., 2011) , STN neurons exhibit maladaptive synaptic plasticity that is driven by the engagement of intrinsic, homeostatic, regulatory mechanisms following loss of dopamine.
In summary, this study demonstrates that hyperdirect pathway motor cortical inputs to the STN regulate the strength of indirect pathway GPe-STN inhibition. Under normal conditions, this heterosynaptic regulation is homeostatic and balances cortical excitation with an appropriate level of GPe inhibition. However, in the absence of dopamine, GPe-STN inhibition is phase-offset to motor cortex-STN excitation, leading to increased activation of STN NMDARs and profound strengthening of GPe-STN transmission, which may, in turn, promote pathological activity.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for further details.
Animals Experiments were performed in accordance with institutional, NIH, and Society for Neuroscience guidelines using adult male C57BL/6 mice or Grin1 lox/lox (B6.129S4-Grin1 tm2Stl /J) mice.
Stereotaxic Injection of Viral Vectors and 6-OHDA AAV vectors were injected stereotaxically under isoflurane anesthesia. AAV expressing hChR2(H134R)-eYFP was injected bilaterally into the primary motor cortex of C57BL/6 mice. AAV expressing eGFP or cre-eGFP was injected unilaterally in the STN of Grin1 lox/lox mice. To lesion midbrain dopamine neurons or control for surgical injection, 6-OHDA (3-5 mg/ml) or vehicle was injected into the medial forebrain bundle. The selectivity and toxicity of 6-OHDA were enhanced through intraperitoneal injection of desipramine and pargyline, respectively. Brain slices were prepared from AAV-, 6-OHDA-, and vehicle-injected mice 2-3 weeks after injection.
Slice Preparation AAV-injected and naive mice were anesthetized with ketamine/xylazine or isoflurane and perfused transcardially with sucrose-based artificial cerebrospinal fluid (ACSF) at 1 C-4 C. Parasagittal brain slices (electrophysiology, 250 mm;
immunohistochemistry, 200 mm) containing the motor cortex and/or STN were prepared in the same solution using a vibratome. Slices were held in ACSF at 35 C for 30 min and then at room temperature until recording.
Electrophysiology, Optogenetic, and Chemical Stimulation For electrophysiological recording and optogenetic or chemical stimulation, slices were transferred to a recording chamber, perfused at a rate of $5 ml/min with synthetic interstitial fluid (SIF) at 35 C-37 C. CGP55845 (2 mM) was added to inhibit GABA B Rs. Somatic patch-clamp recordings were obtained using glass micropipettes filled with either (1) a K + -gluconate-based solution or (2) a Cs + -methanesulfonate-based solution. Signals were low pass-filtered at 10 kHz and sampled at 20-50 kHz. Electrode capacitance was compensated, and data were not included if series resistance changed >20%. For sIPSC and mIPSC recordings, series resistance and whole-cell capacitance were compensated. Liquid junction potentials were corrected online.
IPSCs were evoked by electrical stimulation of the internal capsule rostral to the STN and recorded in the additional presence of DNQX (20 mM) in voltageclamp mode at À60 mV using pipette solution 1. sIPSCs and mIPSCs were recorded at 0 mV using pipette solution 2. sIPSCs were recorded in the presence of D-APV (50 mM). mIPSCs were recorded in the presence of D-APV (50 mM), DNQX (20 mM), and tetrodotoxin (0.5 mM). Optogenetic excitation was delivered via a 633 objective lens using a 470 nm light-emitting diode. Chemical excitation was mediated through application of NMDA (50 mM) in SIF at 35 C-37 C for 5 min.
Two-Photon Imaging and RuBi-GABA Uncaging eGFP/cre-eGFP-expressing and Alexa Fluor 594-filled STN neurons were imaged using 2PLSM at 820 nm with 76 MHz pulse repetition and $250 fs pulse duration at the sample plane. Alexa Fluor 594 (20 mM) was applied via pipette solution 1 to visualize individual STN neurons for uncaging experiments. RuBi-GABA (10-20 mM) was applied via SIF and uncaged using 473 nm light targeted to the soma or dendrite of the recorded neuron (power, 20-30 mW; duration, 1 ms). DNQX (20 mM) and CGP55845 (2 mM) were applied throughout.
Immunohistochemistry eYFP, eGFP, and immunofluorescent labeling were visualized using confocal laser-scanning microscopy. To visualize expression of AAV vectors in the motor cortex and STN, brain slices were immersion fixed in 4% PFA at 4 C following recording. Slices were then washed in PBS and mounted on glass slides and coverslipped. Dopaminergic innervation in 6-OHDA-and vehicle-injected mice was assessed through immunohistochemistry for TH, as described previously (Fan et al., 2012) . Following incubation in ACSF for 1 hr, a subset of slices was subjected to optogenetic or chemical excitation, as stated above, to induce hLTP. 40 min after excitation, slices were immersion-fixed in 4% PFA at room temperature for 15 min. After washing in PBS, slices were incubated in primary antibodies: mouse anti-gephyrin and/or rabbit anti-g2 GABA A R subunit or mouse antivGAT and guinea pig anti-bassoon in PBS plus 0.3% Triton X-100 and 2% normal donkey serum for 48 hr at 4 C. After washing, slices were incubated in fluorescent secondary antibodies, Alexa Fluor 594 donkey anti-mouse IgG (to detect gephyrin), Alexa Fluor 488 donkey anti rabbit IgG (to detect g2 GABA A R subunits), Alexa Fluor 594 donkey anti-mouse IgG (to detect vGAT), and Alexa Fluor 488 donkey anti guinea pig IgG (to detect bassoon) for 2 hr at room temperature. Slices were then mounted on glass slides and coverslipped, and images of immunoreactivity were acquired using confocal microscopy. The densities of immunoreactive structures were assessed using ImageJ (NIH) and quantified using the optical dissector method (West, 1999) while blinded to the experimental manipulation. 
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